13F filer · CIK 914208 ↗
Invesco Ltd.
You are looking at Q3 2017. See the latest, Q2 2026 →
Reported value
$270.72B
−16% on the quarter before
Positions
3,644
108 new · 144 sold out
Top 10
14.8%
of the value
Est. gain
+$10.42B
on stocks held all quarter
Est. return
+4.2%
on those stocks since Q2 2017
Positions as of Sep 30, 2017, from Invesco Ltd.'s 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 23% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.
Largest buys
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Baker Hughes~$279.0MNew · 0.0% → 0.1%+7,618,666 shares
- American Intl Group Inc~$254.0MAdded · 0.1% → 0.2%+4,137,487 shares
- Bristol Myers Squibb Co~$231.6MAdded · 0.2% → 0.3%+3,633,461 shares
- Dowdupont Inc~$164.6MNew · 0.0% → 0.1%+2,377,375 shares
- Anadarko Pete Corp~$164.3MAdded · 0.0% → 0.1%+3,362,870 shares
- Mckesson Corp~$160.5MAdded · 0.1% → 0.2%+1,045,034 shares
- Fiat Chrysler Automobiles N~$149.3MAdded · 0.0% → 0.1%+8,338,654 shares
- China Biologic Prods Hldgs I~$123.7MNew · 0.0% → 0.0%+1,340,556 shares
- Banco Bradesco S A~$119.2MAdded · 0.1% → 0.2%+10,764,487 shares
- Knight Swift Transn Hldgs In~$119.0MNew · 0.0% → 0.0%+2,864,962 shares
Largest sells
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Royal Bk Of Scotland Plc~$9.43BSold out · 2.9% → 0.0%−86,870,000 shares
- Royal Bk Of Scotland Plc~$8.92BSold out · 2.8% → 0.0%−86,390,000 shares
- Hsbc Hldgs Plc~$6.26BSold out · 1.9% → 0.0%−60,500,000 shares
- Royal Bk Scotland Group Plc~$6.06BSold out · 1.9% → 0.0%−55,590,000 shares
- Barclays Bk Plc~$4.20BSold out · 1.3% → 0.0%−40,390,000 shares
- Standard Chartered Plc~$3.14BSold out · 1.0% → 0.0%−30,700,000 shares
- Ing Groep N V~$3.01BSold out · 0.9% → 0.0%−29,400,000 shares
- Hsbc Hldgs Plc~$2.66BSold out · 0.8% → 0.0%−25,030,000 shares
- Hsbc Hldgs Plc~$2.56BSold out · 0.8% → 0.0%−24,430,000 shares
- Lloyds Banking Group Plc~$2.47BSold out · 0.8% → 0.0%−22,365,000 shares
Holdings
As of Sep 30, 2017. Changes are in shares against Jun 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −3.4% · price +7.0% | 2.7% | $7.40B | +$485.1M | ||||||||
| MicrosoftCOM · shares −1.6% · price +8.1% | 2.3% | $6.12B | +$456.8M | ||||||||
| AmazonCOM · shares −0.2% · price −0.7% | 1.8% | $4.82B | −$33.3M | ||||||||
| MetaCL A · shares +0.5% · price +13.2% | 1.6% | $4.27B | +$494.7M | ||||||||
| AlphabetCAP STK CL A · shares −3.8% · price +4.7% | 1.3% | $3.39B | +$153.2M | ||||||||
| AlphabetCAP STK CL C · shares +0.4% · price +5.5% | 1.2% | $3.29B | +$172.2M | ||||||||
| Citigroup IncCOM NEW · shares −3.1% · price +8.8% | 1.2% | $3.24B | +$261.1M | ||||||||
| CiscoCOM · shares −2.6% · price +7.4% | 1.0% | $2.74B | +$190.0M | ||||||||
| Comcast Corp NewCL A · shares −0.9% · price −1.1% | 0.88% | $2.37B | −$27.1M | ||||||||
| Bank Amer CorpCOM · shares −2.2% · price +4.5% | 0.87% | $2.36B | +$100.7M | ||||||||
| Jpmorgan Chase & CoCOM · shares −9.2% · price +4.5% | 0.87% | $2.35B | +$101.0M | ||||||||
| IntelCOM · shares +2.6% · price +12.9% | 0.82% | $2.23B | +$247.8M | ||||||||
| Broadcom LtdSHS · shares −0.6% · price +4.1% | 0.67% | $1.80B | +$70.5M | ||||||||
| BaiduSPON ADR REP A · shares −8.9% · price +38.5% | 0.66% | $1.79B | +$497.8M | ||||||||
| Celgene CorpCOM · shares −1.8% · price +12.3% | 0.66% | $1.78B | +$195.1M | ||||||||
| Suncor Energy Inc NewCOM · shares −3.1% · price +20.0% | 0.63% | $1.70B | +$283.0M | ||||||||
| Amgen IncCOM · shares +0.4% · price +8.3% | 0.63% | $1.69B | +$128.7M | ||||||||
| AlibabaSPONSORED ADS · shares −3.5% · price +22.6% | 0.58% | $1.56B | +$287.3M | ||||||||
| Walgreens Boots Alliance IncCOM · shares −1.7% · price −1.4% | 0.56% | $1.53B | −$21.6M | ||||||||
| Gilead Sciences IncCOM · shares +4.4% · price +14.5% | 0.53% | $1.44B | +$174.6M | ||||||||
| Pfizer IncCOM · shares −3.3% · price +6.3% | 0.52% | $1.40B | +$82.8M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −13% · price +7.9% | 0.49% | $1.33B | +$97.7M | ||||||||
| AT&TCOM · shares −1.3% · price +3.8% | 0.49% | $1.31B | +$48.3M | ||||||||
| Charter Communications Inc NCL A · shares +1.8% · price +7.9% | 0.49% | $1.31B | +$94.4M | ||||||||
| Ebay IncCOM · shares −1.0% · price +10.1% | 0.48% | $1.29B | +$119.0M | ||||||||
| Total · 3,644 positions | 100% | $270.72B | +$10.42B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2017 to Q3 2017: 3,429 stocks held throughout, up $10.42B (+4.2%).
- Baidu+$497.8M+38%
- Meta+$494.7M+13%
- Apple+$485.1M+7%
- Microsoft+$456.8M+8%
- Alibaba+$287.3M+23%
- Mylan N V−$99.8M−19%
- Newell Brands Inc−$107.0M−20%
- Kraft Heinz Co−$119.8M−9%
- Netease Inc−$138.5M−12%
- Teva Pharmaceutical Inds Ltd−$190.8M−47%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $1.26T+23% | SEC ↗ |
| Q1 2026 | May 12, 2026 (amended) | $1.02T−3% | SEC ↗ |
| Q4 2025 | Feb 19, 2026 (amended) | $1.06T+67% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $634.72B+8% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $587.99B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $527.93B−2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $540.90B+4% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $517.95B+10% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $472.84B+2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $465.56B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $420.24B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $371.30B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $381.45B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $358.48B+5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $341.42B+10% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $310.69B−6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $330.04B−16% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $392.05B−5% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $414.84B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $394.59B−3% | SEC ↗ |
| Q2 2021 | Aug 17, 2021 | $406.58B+9% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $374.71B+9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $343.59B+16% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $295.82B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $279.68B+18% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $237.58B−26% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $322.08B−16% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $382.36B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 (amended) | $388.53B+31% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $296.53B+14% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $261.24B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $317.79B+5% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $302.15B+13% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $267.56B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $277.31B+2% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.72B−16% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $321.34B+5% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $304.59B+2% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $297.54B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $291.04B+7% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $272.23B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $246.04B | SEC ↗ |